Purpose
Abnormal ocular biomechanical properties may be important for understanding the risk of glaucoma. However, there are no clinical methods for measuring standard material properties in patients. In this feasibility study we demonstrated proof-of-principle for a novel method, ultrasound surface wave elastography (USWE), to determine the in vivo Young’s modulus of elasticity of corneas in normal human eyes.
Methods
Twenty eyes of 10 healthy subjects (mean age 51.4 ± 7.2; ± SD, range 43–64 years) were studied. A spherical-tipped probe (3-mm diameter) was placed on closed eyelids and generated a gentle harmonic vibration at 100 Hz for 0.1 second. Wave speed propagation in the cornea was measured by USWE, and Young’s modulus was calculated from the wave speed. Associations between Young’s modulus and intraocular pressure (IOP), age, central corneal thickness, and axial length were explored by Pearson correlation. Statistical significance was determined by using generalized estimating equation models to account for possible correlation between fellow eyes.
Results
Mean IOP was 12.8 ± 2.7 mmHg. Mean wave speed in the cornea was 1.82 ± 0.10 m/s. Young’s modulus of elasticity was 696 ± 113 kPa and was correlated with IOP (r=0.57; p=0.004), but none of the other variables (p>0.1).
Conclusions
USWE is a novel non-invasive technique for measuring ocular biomechanical properties. Corneal Young’s modulus in normal eyes is associated with IOP, consistent with measurements in cadaver eyes. Further work is needed to determine elasticity in other ocular tissues, particularly the sclera, and if elasticity is altered in glaucoma patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.